NEW YORK – Accelerate Diagnostics reported on Monday that its preliminary fourth quarter revenues rose 94 percent but still fell short of the company's expectations.
For the quarter ended December 30, 2019 Accelerate Diagnostics expects total revenues of $3.5 million, up from $1.8 million in the year-ago quarter. For the full year, total revenue is expected to be $9.3 million, up 63 percent compared to its full-year 2018 revenues of $5.7 million.
The analysts' average estimates were for Q4 revenues of $4.8 million and for full-year revenues of $10.7 million.